AXCELLA

axcella-logo

Axcella is a clinical-stage biotechnology company that treats complex diseases using endogenous metabolic modulator (EMM) compositions. They combine biological pathways with developments in systems biology and machine learning. Their proprietary platform is clinically validated across several indication areas, with clinical-stage candidates in muscle, neurodegenerative, and liver conditions.

#SimilarOrganizations #People #Financial #Website #More

AXCELLA

Social Links:

Industry:
Biotechnology Life Science Pharmaceutical Therapeutics

Founded:
2010-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.axcellatx.com

Total Employee:
51+

Status:
Active

Contact:
+1 617 441 6243

Total Funding:
185.5 M USD

Technology used in webpage:
Akamai Hosted


Similar Organizations

aclaris-therapeutics-logo

Aclaris Therapeutics

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

again-life-usa-logo

Again Life U.S.A.

Again Life U.S.A. is a pharmaceutical biotechnology company that provides research and the development of its biotechnological platform.

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

enveda-biosciences-logo

Enveda Biosciences

Enveda Biosciences is a biotechnology company building new medicines from plants.

iroko-pharmaceuticals-logo

Iroko Pharmaceuticals

Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.

syros-pharmaceuticals-logo

Syros Pharmaceuticals

Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.

tcr2-logo

TCR2

TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuC™ platform.

young-therapeutics-logo

Young Therapeutics

Young Therapeutics is a biotechnology company that treats ischemia or reperfusion injury.


Current Advisors List

david-berry_image

David Berry Board Member @ Axcella
Board_member
2009-01-01

geoffrey-von-maltzahn_image

Geoffrey von Maltzahn Scientific Advisory Board @ Axcella
Advisor

stuart-phillips_image

Stuart Phillips Scientific Advisory Board @ Axcella
Advisor

gary-pisano_image

Gary Pisano Board Member @ Axcella
Board_member

robert-r-wolfe_image

Robert R. Wolfe Scientific Advisory Board @ Axcella
Advisor

jerry-hjelle_image

Jerry Hjelle Scientific Advisory Board @ Axcella
Advisor

cheryl-morley_image

Cheryl Morley Member of the Advisory Board @ Axcella
Advisor

chris-viehbacher_image

Chris Viehbacher Board Member @ Axcella
Board_member

Current Employees Featured

david-epstein_image

David Epstein
David Epstein Chairman Of The Board @ Axcella
Chairman Of The Board
2017-12-01

heidy-king-jones_image

Heidy King-Jones
Heidy King-Jones Senior Vice President, General Counsel & Corporate Secretary @ Axcella
Senior Vice President, General Counsel & Corporate Secretary
2019-11-01

tony-tramontin_image

Tony Tramontin
Tony Tramontin Senior Vice President of Research & Development, Chief Scientific Officer @ Axcella
Senior Vice President of Research & Development, Chief Scientific Officer
2017-06-01

david-berry_image

David Berry
David Berry Founder @ Axcella
Founder
2009-01-01

paul-fehlner_image

Paul Fehlner
Paul Fehlner Senior Vice President & Chief Intellectual Property Officer @ Axcella
Senior Vice President & Chief Intellectual Property Officer
2018-04-01

jeff-moore_image

Jeff Moore
Jeff Moore CFO @ Axcella
CFO
2011-08-01

geoffrey-von-maltzahn_image

Geoffrey von Maltzahn
Geoffrey von Maltzahn Co-Founder @ Axcella
Co-Founder
2009-01-01

laurent-chardonnet_image

Laurent Chardonnet
Laurent Chardonnet Senior Vice President & Chief Financial Officer @ Axcella
Senior Vice President & Chief Financial Officer
2019-11-01

shreeram-aradhye_image

Shreeram Aradhye
Shreeram Aradhye Chief Development Officer and Board Member @ Axcella
Chief Development Officer and Board Member
2019-05-01

stephen-mitchener_image

Stephen Mitchener
Stephen Mitchener Senior Vice President & Chief Business Officer @ Axcella
Senior Vice President & Chief Business Officer
2018-09-01

Founder


david-berry_image

David Berry

geoffrey-von-maltzahn_image

Geoffrey von Maltzahn

noubar-afeyan_image

Noubar Afeyan

Stock Details


Company's stock symbol is NASDAQ:AXLA

Investors List

fidelity-investments_image

Fidelity

Fidelity investment in Series E - Axcella

nestl-health-science_image

Nestlé Health Science

Nestlé Health Science investment in Series E - Axcella

flagship-ventures_image

Flagship Pioneering

Flagship Pioneering investment in Series E - Axcella

nestl-health-science_image

Nestlé Health Science

Nestlé Health Science investment in Series D - Axcella

fidelity-investments_image

Fidelity

Fidelity investment in Series C - Axcella

rajiv-kaul-2_image

Rajiv Kaul

Rajiv Kaul investment in Series C - Axcella

flagship-ventures_image

Flagship Pioneering

Flagship Pioneering investment in Series C - Axcella

ensoventures_image

Enso Ventures

Enso Ventures investment in Series B - Axcella

flagship-ventures_image

Flagship Pioneering

Flagship Pioneering investment in Series B - Axcella

flagship-ventures_image

Flagship Pioneering

Flagship Pioneering investment in Series A - Axcella

Official Site Inspections

http://www.axcellatx.com Semrush global rank: 574.41 K Semrush visits lastest month: 56.64 K

  • Host name: 172.67.138.227
  • IP address: 172.67.138.227
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Axcella"

Axcella - Crunchbase Company Profile & Funding

Axcella is a clinical-stage biotechnology company that treats complex diseases using endogenous metabolic modulator (EMM) compositions. They combine biological pathways with developments in systems biology and machine learning.See details»

Axcella - LinkedIn

Axcella is a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using endogenous metabolic modulator (EMM) compositions.See details»

Axcella Company Profile | Management and Employees List

[email protected]: 5: first: [email protected]: 6: last: [email protected]: Your Questions, Our Answers Get Free Access to Axcella Contacts Info. What is Axcella revenue? Axcella revenue is $19.9 M. How many employees does Axcella have? Axcella has 59 …See details»

Axcella Overview | SignalHire Company Profile

Organization Website. axcellatx.com . Social Links. Contact Email [email protected] Phone Number. 857-320-2200,617-441-6243. Axcella industries. Biotech, Biotechnology Headquarters Location. 840 Memorial Drive, Cambridge, MA, 02139 US. Axcella Employees Size. 100-200 …See details»

Company Profile for Axcella Health Inc. - Business Wire

Sep 24, 2020 Company: Axcella Health Inc. Headquarters Address: 840 Memorial Dr., Third Floor CAMBRIDGE, MA 02139 Main Telephone: 857-320-2200See details»

Axcella - Overview, News & Similar companies | ZoomInfo.com

Oct 29, 2023 View Axcella (www.axcellatx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»

Axcella Announces FDA IND Clearance Supporting Regulatory …

Feb 15, 2023 The forum is co-sponsored by the Biotechnology Innovation Organization (BIO) and SOLVE M.E., a non-profit organization that serves as a catalyst for critical research into diagnostics, treatments ...See details»

Axcella Announces Regulatory Path to Registration of AXA1125 for …

Jan 23, 2023 Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering novel approaches to treating complex diseases using multi-targeSee details»

Axcella Therapeutics - VentureRadar

Website: https://axcellatx.com/ Develops multi-targeted endogenous metabolic modulator (EMM) compositions to address complex diseases by leveraging systems biology ...See details»

Flagship-founded Axcella folds - Fierce Biotech

Dec 5, 2023 Flagship-founded Axcella Health is closing its doors, with stockholders approving the dissolution of the metabolic modulator biotech yesterday.. Founded by Flagship Pioneering in 2011, the public ...See details»

Axcella Therapeutics - VentureRadar

Open PageRank: 5,750,302 | axcellatx.com. VentureRadar Popularity. Medium. VentureRadar Popularity: Medium. The popularity score combines profile views, clicks and the number of times the company appears in search results. Upgrade for full access. You have reached your free …See details»

Axcella Announces Program Reprioritization and Corporate …

Dec 15, 2022 Axcella is realigning the organization to correspond to this shift in strategy and reprioritization of its programs, reducing its workforce by 85 percent, retaining certain employees to execute the strategic process. Among the departing employees are Bob Crane, Chief …See details»

Working At Axcella: Company Overview and Culture - Zippia

Mar 14, 2024 axcellatx.com. Organization Type. Public. Social Media. Axcella Health is pioneering revolutionary new medicines with a focus on amino acid homeostasis. The company has discovered more than 2,000 diseases with amino acid imbalances and developed a …See details»

Axcella Announces Program Reprioritization and Corporate …

Dec 15, 2022 Axcella is realigning the organization to correspond to this shift in strategy and reprioritization of its programs, reducing its workforce by 85 percent, retaining certain employees to execute ...See details»

Axcella Announces FDA IND Clearance Supporting Regulatory

Feb 15, 2023 The forum is co-sponsored by the Biotechnology Innovation Organization (BIO) and SOLVE M.E., a non-profit organization that serves as a catalyst for critical research into diagnostics, treatments, and cures for myalgic encephalomyelitis/chronic fatigue syndrome …See details»

Robert Crane - Chief Financial Officer at Axcella | ZoomInfo

Feb 26, 2024 Robert Crane’s email address is r***@axcellatx.com What is Robert Crane’s business email address? ... Robert Crane serves as Chief Financial Officer for the organization. Mr. Crane joined Axcella in 2022, bringing more than 35 years of experience building …See details»

Axcella Therapeutics Announces $34.2 Million Registered Direct …

Oct 13, 2022 Prior to joining Flagship, Mr. Straight Nissen headed up Strategic Portfolio Management for Pfizer's worldwide R&D organization where he oversaw Pfizer's portfolio spanning discovery to Phase 2b ...See details»

WHAT IS ORGANIZATIONAL EXCELLENCE? - AKAP Accreditation …

An organization is a group aggregated and combined under specific leadership to function as a single entity for a particular purpose. Excellence is a measure of consistently superior performance that surpasses requirements and expectations without demonstrating significant …See details»

Axcella Therapeutics Launches Clinical Program to ... - Business Wire

Oct 26, 2021 A webcast of this event can be accessed by visiting the “Investors & News” section of the company’s website, www.axcellatx.com. A webcast replay will be available for 90 days following the ...See details»

Axcella, Now Axcella Therapeutics, to Host Virtual R&D Day on …

Oct 19, 2021 A live audio webcast of this event will be available on the “Investors & News” section of the company’s website, www.axcellatx.com. A replay will also be available on Axcella’s website for ...See details»

linkstock.net © 2022. All rights reserved